Can fish oil boost Tamoxifen's power to prevent breast cancer?
NCT ID NCT06195306
First seen Jun 27, 2026 · Last updated Aug 05, 2026 · Updated 2 times
Summary
This study tests whether adding high-dose omega-3 fatty acids to low-dose tamoxifen can lower breast cancer risk more than tamoxifen alone. It includes 66 overweight or obese postmenopausal women at increased risk for breast cancer. The goal is to see if the combination improves certain blood markers linked to cancer risk.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST ATYPICAL HYPERPLASIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ohio State University Comprehensive Cancer Center
RECRUITINGColumbus, Ohio, 43210, United States
-
University of Kansas Cancer Center
RECRUITINGKansas City, Kansas, 66160, United States
-
University of Michigan Rogel Cancer Center
RECRUITINGAnn Arbor, Michigan, 48109, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Phone-Based navigation could boost breast cancer detection in kenya
- Fasting during chemo: a new way to boost treatment?
- Digital therapy aims to tame the fear that haunts cancer survivors
- Can an immune booster help chemotherapy fight metastatic breast cancer?
- Can a sticky film shield breast cancer patients from radiation burns in tropical heat?
- Can a simpler, cheaper method for marking breast tumors work as well as ultrasound?